Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by Red5Lukeon Jul 23, 2018 3:50pm

199 Views

Post# 28354895

Howard touched down in China?

‏ @SironaBiochem Jul 12

The company also continues to make great progress with TFC-1067 and have scheduled follow-up meetings with leading pharmaceutical as well as cosmetic companies in China which are being held in less than two weeks. #cosmeceuticals #derm

I wonder if Howard and gang have landed in China for their meetings? Would be nice for him to come back with $500 USD payment from Wanbang and a term sheet for the 1067 from an Asian big pharma. Dare to dream.

Bullboard Posts

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles